Back to search

Peptide record

TPDB09194

Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09194
Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia B3Pred BBPpredict CPPsite3.0
standard
No
A 19-aa standard natural multi-activity (Antibacterial, Anticancer, Blood-Brain Barrier, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
VDKPPYLPRPRPPRRIYNR
Physicochemical Analysis
C109H176N36O25
ACEQGHMFSTW
P
2390.82
11.84
6
1
5
+5
6.71
-1.742
56.32
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
2980
124.64
3
Residue Composition
number
0
A
5
R
1
N
1
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
1
K
0
M
0
F
6
P
0
S
0
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 5 N: 1 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 1 M: 0 F: 0 P: 6 S: 0 T: 0 W: 0 Y: 2 V: 1
Chemical Descriptors
19
C109H176N36O25
2390.82
11.84
+5
6.71
-1.742
Evidence Records 2 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 2 ug/ml).
Evidence 2 Activity

Activity

0% Hemolysis
Toxicity
512 µM
Hemolytic Cytotoxic
0% Hemolysis | 512 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2. | Int J Pept Res Ther | 2019